Kate Leinbaugh

Hims is part of the parent company, Hims and Hers Health, which went public in 2021.

The main way HIMS and its rival companies get customers is through aggressive TV and social media ads.

The main way HIMS and its rival companies get customers is through aggressive TV and social media ads.

The main way HIMS and its rival companies get customers is through aggressive TV and social media ads.

Are they like tapping sort of fundamental insecurities?

Are they like tapping sort of fundamental insecurities?

Are they like tapping sort of fundamental insecurities?

The way these telehealth ads handle side effects is very different from the usual drug commercial.

The way these telehealth ads handle side effects is very different from the usual drug commercial.

The way these telehealth ads handle side effects is very different from the usual drug commercial.

But changes could be coming for telehealth advertising. This past February, HIMSS had a minute-long ad during the Super Bowl for its GLP-1 medication, its version of Ozempic. Obesity is America's deadliest epidemic. This is America. 74% of us are overweight.

But changes could be coming for telehealth advertising. This past February, HIMSS had a minute-long ad during the Super Bowl for its GLP-1 medication, its version of Ozempic. Obesity is America's deadliest epidemic. This is America. 74% of us are overweight.

But changes could be coming for telehealth advertising. This past February, HIMSS had a minute-long ad during the Super Bowl for its GLP-1 medication, its version of Ozempic. Obesity is America's deadliest epidemic. This is America. 74% of us are overweight.

Hims defended the ad, saying the company provides a telehealth platform and isn't a drug manufacturer. The senators have since introduced a bill called the Protecting Patients from Deceptive Drug Ads Act. While telehealth companies are able to market their services without the burden of disclosing side effects, they are required to disclose side effects somewhere on their websites.

Hims defended the ad, saying the company provides a telehealth platform and isn't a drug manufacturer. The senators have since introduced a bill called the Protecting Patients from Deceptive Drug Ads Act. While telehealth companies are able to market their services without the burden of disclosing side effects, they are required to disclose side effects somewhere on their websites.

Hims defended the ad, saying the company provides a telehealth platform and isn't a drug manufacturer. The senators have since introduced a bill called the Protecting Patients from Deceptive Drug Ads Act. While telehealth companies are able to market their services without the burden of disclosing side effects, they are required to disclose side effects somewhere on their websites.

And that's what happened to Mark Millick.

And that's what happened to Mark Millick.

And that's what happened to Mark Millick.

Mark started taking the medication he'd bought online. But it didn't go as he'd hoped. That's next.